We are leading exporter of Natdac to Russia. Natdac (Daclatasvir Dihydrochloride) is a treatment for chronic hepatitis C virus (HCV) genotype 1 or genotype 3 infection. It is always prescribed with sofosbuvir, and depending on the genotype and underlying medical conditions, with or without ribavirin.
Daclatasvir (NatDac) is the first-in-class NS5A inhibitor used in combination with Sofosbuvir for the treatment of patients with chronic hepatitis C virus (HCV) genotype 3 infection. Compared to other treatment options, this combination not only increases the cure rate, but is also regarded as a valuable treatment option in some of the difficult-to-treat HCV patient subsets.
NATDAC 60 mg -
Brand Name: Natdac
Manufactured by: Natco Pharma Ltd.
Strengths: 60 mg
Packing: Pack of 28 Tablets